Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine rich nucleolar protein 1 pseudogene 5 (KNOP1P5)
- Target
- KNOP1P5
- Molecular classification
- Other, Pseudogene
01
Overview
KNOP1P5 (lysine rich nucleolar protein 1 pseudogene 5) is classified as a human pseudogene located in the genome and annotated in gene databases (e.g., NCBI Gene, GeneCards). It does not encode a protein, nor does it function as a receptor or enzyme. Like other pseudogenes, it may have potential roles in the regulation of its parental gene through noncoding RNA mechanisms (e.g., microRNA decoy function or generation of siRNAs). However, there is no evidence for a direct biological, disease, or therapeutic relevance for this specific pseudogene. It is not considered a canonical drug target, and its utility to therapy or biomarker development has not been established.
- Other names
- Lysine rich nucleolar protein 1 pseudogene 5KNOP1P5HGNC:48923NCBI Gene:100130158Ensembl:ENSG00000250563
02
Mechanism of action
Not applicable. No drugs target KNOP1P5 and no mechanism is described.
03
Biological functions
No direct biological function attributed to KNOP1P5 itself.Pseudogenes in general can regulate parent gene expression through noncoding RNA mechanisms.Pseudogenes in general can serve as microRNA decoys or sources of small interfering RNAs (siRNAs).Pseudogenes in general can possibly modulate coding gene mRNA stability in some cases.No tissue-specific or disease-related biological function for KNOP1P5 itself is described in available sources.
04
Disease associations
No direct disease association or implication for KNOP1P5.Pseudogenes in general have been implicated in cancer, via regulation of parent gene expression or microRNA/siRNA pathways.No evidence tying this specific pseudogene to inflammation, neurological, cardiovascular, infectious, or other diseases.
05
Safety considerations
Not applicable. As a non-coding pseudogene, KNOP1P5 presents no notable safety, toxicity, or therapeutic challenges specific to its manipulation.
06
Interacting drugs
None reported. There are no drugs known to target, bind, or interact with KNOP1P5 or its transcript.
07
Biomarkers
None reported. KNOP1P5 is not used as a biomarker for patient selection or treatment monitoring in any indication.
Beyond the preview
Go deeper on Lysine rich nucleolar protein 1 pseudogene 5 (KNOP1P5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lysine rich nucleolar protein 1 pseudogene 5 (KNOP1P5).